Lycopene II - Effect on osteoblasts: The carotenoid lycopene stimulates cell proliferation and alkaline phosphatase activity of SaOS-2 cells

Journal of Medicinal Food

Volumn 6, Issue 2, 2003, Pages 79-86

  Kim, Linda ^a   Rao, A Venket ^a   Rao, Leticia G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CAROTENOID; DEXAMETHASONE; LYCOPENE;

ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DILUTION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MICROEMULSION; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; OSTEOSARCOMA CELL; PRIORITY JOURNAL; TOMATO;

LYCOPERSICON ESCULENTUM;

EID: 0141707776     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/109662003322233468     Document Type: Article

References (42)

1. Raisz LG: Osteoporosis: Current approaches and future prospects in diagnosis, pathogenesis, and management. J Bone Miner Metab 1999;17:79-109.
2. Lindsay R, Cosman F: Prevention of osteoporosis: In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th Ed. (Favus MJ, ed.). Lippincott Williams & Wilkins, New York, 1999, pp. 264-269.
3. Raisz LG: Pathogenesis of postmenopausal osteoporosis. Rev Endocr Metab Disord 2001;2:5-12.
4. Morton DJ, Barrett-Connor EL, Schneider DL: Vitamin C supplement and bone mineral density in postmenopausal women. J Bone Miner Res 2001;16:135-140.
5. Singh VN: A current perspective on nutrition and exercise. J Nutr 1992;122:760-765.
6. Melhus H, Michaelsson K, Holmberg L, Wolk A, Ljunghall S: Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 1999;14:129-135.
7. Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H: Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 2001; 288:275-279.
8. Varanasi SS, Francis RM, Berger CE, Papiha SS, Datta HK: Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int 1999;10:143-149.
9. Mundy GR: Bone remodelling. In: Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th Ed. (Favus MJ, ed.). Lippincott Williams & Wilkins, New York, 1999, pp. 30-42.
10. Lian JB, Stein GS, Canalis E, Gehron Robey P, Boskey AL: Bone formation: Osteoblast lineage cells, growth factors, matrix proteins, and the mineralization process. In: Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th Ed. (Favus MJ, ed.). Lippincott Williams & Wilkins, New York, 1999, pp. 14-29.
11. Berger CE, Horrocks BR, Datta HK: Direct non-genomic effect of steroid hormones on superoxide anion generation in the bone resorbing osteoclasts. Mol Cell Endocrinol 1999;149:53-59.
12. Schaeublin M, Jeker H, Fuller K, Chambers TJ: The role of reactive oxygen intermediates in osteoclastic bone resorption. Biochem Biophys Res Commun 1995; 207:280-287.
13. Gasbarrini A, Grigolo B, Serra M, Baldini N, Scotlandi K, Bernardi M, Facchini A: Generation of free radicals during anoxia and reoxygenation in perfused osteoblastlike cells. Clin Orthop 1997;338:247-252.
14. Cortizo AM, Bruzzone L, Molinuevo S, Etcheverry SB: A possible role of oxidative stress in the vanadium-induced cytotoxicity in the MC3T3E1 osteoblast and UMR106 osteosarcoma cell lines. Toxicology 2000;147: 89-99.
15. Park CK, Ishimi Y, Ohmura M, Yamaguchi M, Ikegami S: Vitamin A and carotenoids stimulate differentiation of mouse osteoblastic cells. J Nutr Sci Vitaminol 1997;43:281-296.
16. Rao AV, Waseem S, Agarwal S: Lycopene content of tomatoes and tomato products and their contribution to dietary lycopene. Food Res Int 1998;31:737-741.
17. Agarwal A, Shen H, Agarwal S, Rao AV: Lycopene content of tomato products: Its stability, bioavailability and in vivo antioxidant properties. J Med Food 2001;4:9-15.
18. Rao AV, Agarwal S: Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: A review. Nutr Res 1999;19:305-323.
19. Di Mascio P, Kaiser S, Sies H: Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989;274:532-538.
20. Agarwal S, Rao AV: Tomato lycopene and its role in human health and chronic diseases. Can Med Assoc J 2000;163:739-744.
21. Rao AV, Agarwal S: Role of antioxidant lycopene in cancer and heart disease. J Am Coll Nutr 2000;19:563-569.
22. Rao A, Agarwal S: Effect of diet and smoking on serum lycopene and lipid peroxidation. Nutr Res 1998;18:713-721.
23. Rao LG, Wylie JN, Kung-Sutherland MS, Murray TM: 17β-Estradiol and parathyroid hormone potentiate each other's stimulatory effects on alkaline phosphatase activity in SaOS-2 cells in a differentiation-dependent manner. Endocrinology 1994;134:614-620.
24. 3 on alkaline phosphatase activity in a differentiation-dependent manner. J Endocrinol 1996;148:181-187.
25. Lowry OH: Micromethods for the assay of enzyme II. Specific procedures: Alkaline phosphatase. Methods Enzymol 1955;4:371-372.
26. Liu H-C, Cheng R-M, Lin F-H, Fang H-W: Sintered beta-dicalcium phosphate particles induce intracellular reactive oxygen species in rat osteoblasts. Biomed Eng Appl Basis Commun 1999;11:259-264.
27. Mody N, Parhami F, Sarafian TA, Demer LL: Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001;31: 509-519.
28. Breimer LH: Molecular mechanism of oxygen radical carcinogenesis and mutagenesis: The role of DNA base damage. Mol Carcinog 1990;3:188-197.
29. Beck GR Jr, Zerler B, Moran E: Gene array analysis of osteoblast differentiation. Cell Growth Differ 2001;12: 61-83.
30. Levy J, Bosin E, Feldman B, Giat Y, Miinster A, Danilenko M, Sharoni Y: Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr Cancer 1995;24:257-266.
31. Zhang LX, Cooney RV, Bertram JS: Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: Relationship to their cancer chemopreventive action. Carcinogenesis 1991;12:2109-2114.
32. Lochter A, Usher PA, Foged NT, Delaisse JM: PTH-induced retraction of calvarial osteoblasts requires nuclear translocation of NF-κB. [Abstract] J Bone Miner Res 1999;14:386-395.
33. Rao LG, Murray TM: Studies of human osteoblasts in vitro: Estrogen actions and interactions with other hormones at different stages of differentiation. Drug Dev Res 2000;49:174-186.
34. Wagner AH, Schroeter MR, Hecker M: 17β-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 2001;15:2121-2130.
35. Clarke R, Leonessa F, Welch JN, Skaar TC: Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev 2001;53:25-71.
36. Sawada H, Shimohama S: Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons. Neurosci Biobehav Rev 2000;24:143-147.
37. Farley JR, Hall SJ, Herring S, Tarbaux NM, Matsuyama T, Wergedal JE: Skeletal alkaline phosphatase specific activity is an index of osteoblast phenotype in subpopulations of the human osteosarcoma cell line SaOS-2. Metabolism 1991;40:664-671.
38. Manduca P, Sanguineti C, Pistone M, Boccignone E, Sanguineti F, Federici A: Differential expression of alkaline phosphatase in clones of human osteoblast-like cells. J Bone Miner Res 1993;8:291-300.
39. Rao LG, Liu LJ-F, Murray TM, McDermott E: 17β-Estradiol stimulates bone nodule formation when added intermittently to SaOS-2 cells. Drug Metab Drug Interact 2001;18:149-158.
40. Wasnich RD: Epidemiology of osteoporosis. In: Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th Ed. (Favus MJ, ed.). Lippincott Williams & Wilkins, New York, 1999, pp. 257-259.
41. Mazess RB, Bardin HS: Bone density in postmenopausal women: Effects of age, dietary intake, physical activity, smoking and birth control pills. Am J Clin Nutr 1991;53:132-142.
42. Marcus R: Physical activity and regulation of bone mass. In: Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th Ed. (Favus MJ, ed.). Lippincott Williams & Wilkins, New York, 1999, pp. 262-264.